| Recruiting | WB-EMS Effects on Cardiometabolic Risk Factors NCT07406191 | University of Erlangen-Nürnberg Medical School | N/A |
| Recruiting | Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein C NCT07004777 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | N/A |
| Not Yet Recruiting | A Study of SHR-1918 In Participants With Hypertriglyceridemia NCT07349615 | Beijing Suncadia Pharmaceuticals Co., Ltd | Phase 3 |
| Recruiting | Russian Extreme Hypertriglyceridemia Registry NCT07508930 | Russian Cardiology Research and Production Center | — |
| Recruiting | A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol NCT07199309 | Marea Therapeutics | Phase 2 |
| Recruiting | a Phase 1b/2a Study of JMT202 Injection in Participants With Hypertriglyceridemia NCT07140809 | Shanghai JMT-Bio Inc. | Phase 1 / Phase 2 |
| Recruiting | Differential Thrombogenesis by EPA and DHA Mediated by HDL NCT06494488 | The Miriam Hospital | EARLY_Phase 1 |
| Enrolling By Invitation | A Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Ather NCT07050134 | Junbo Ge | N/A |
| Active Not Recruiting | Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol NCT07028749 | Marea Therapeutics | Phase 2 |
| Recruiting | Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia NCT06822790 | Arrowhead Pharmaceuticals | Phase 3 |
| Active Not Recruiting | Single-ascending Dose Study of Kylo-12 in Healthy Subjects NCT06783881 | Kylonova (Xiamen) Biopharma co., LTD. | Phase 1 |
| Active Not Recruiting | Cardiometabolic Properties of Omega-3 Functionalized With Hydroxytyrosol NCT06992323 | National Research Council, Spain | N/A |
| Active Not Recruiting | Evaluation of the Efficacy of Phospholipid-Bound Omega-3 Versus Omega-3 Alone in Patients With Hypertriglyceri NCT06749028 | Fundación del Caribe para la Investigación Biomédica | N/A |
| Recruiting | Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia NCT06451770 | Verve Therapeutics, Inc. | Phase 1 |
| Active Not Recruiting | Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects NCT06471543 | Ikaria Bioscience Pty Ltd | Phase 1 / Phase 2 |
| Completed | Barberry and Cardiometabolic Risk Factors in Individuals With Hypertriglyceridemia NCT06483932 | Shahid Beheshti University | N/A |
| Not Yet Recruiting | Exploring Physical Exercise for the Regulation and Control of Metabolic Disorders in College Students. NCT06555159 | Universidad de Colima | N/A |
| Recruiting | Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAF NCT06564584 | OrsoBio, Inc | Phase 2 |
| Completed | Response to an Intervention With Omega-3 (RIO - Study) NCT06538324 | Universidad San Sebastián | N/A |
| Recruiting | A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias NCT07491172 | CRISPR Therapeutics AG | Phase 1 |
| Active Not Recruiting | Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia NCT06347133 | Arrowhead Pharmaceuticals | Phase 3 |
| Recruiting | Vitamin C Administration and Triglycerides Level in Critical Care Patients NCT06206759 | Meir Medical Center | — |
| Unknown | A Study on the Effects of Mastiha Oil in Adults With Hypertriglyceridemia NCT06323252 | Harokopio University | N/A |
| Recruiting | Interest of High-speed Centrifugation for Measuring Anti-Xa Activity on Lipemic Plasma NCT07200674 | University Hospital, Strasbourg, France | — |
| Recruiting | Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Wom NCT06220266 | Dhurakij Pundit University | Phase 2 / Phase 3 |
| Unknown | Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes NCT06129526 | University of Ioannina | Phase 4 |
| Recruiting | Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Diff NCT05743868 | Yale University | N/A |
| Completed | Chia Seeds Consumption in Hypertriglyceridemia NCT06020950 | Shahid Beheshti University | N/A |
| Completed | Study of MAR001 in Adults With Metabolic Dysfunction NCT05896254 | Marea Therapeutics | Phase 1 / Phase 2 |
| Completed | A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers NCT05851066 | Visirna Therapeutics HK Limited | Phase 1 |
| Unknown | Effect of Silibinin(A) as a Potential Anti-obesity Agent NCT05069298 | Universidad Católica San Antonio de Murcia | N/A |
| Active Not Recruiting | Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male Subjects NCT05953064 | University Hospital, Gentofte, Copenhagen | N/A |
| Completed | A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascula NCT05610280 | Ionis Pharmaceuticals, Inc. | Phase 3 |
| Terminated | A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia NCT05609825 | Eli Lilly and Company | Phase 1 |
| Unknown | Insulin and Standard Management in Hypertriglyceridemic Acute Pancreatitis NCT05487833 | University Medical Centre Ljubljana | Phase 4 |
| Unknown | Sustainable-psycho-nutritional Intervention Program and Its Effects on Health Outcomes and the Environment NCT05457439 | University of Guadalajara | N/A |
| Active Not Recruiting | MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia NCT05464784 | MediciNova | Phase 2 |
| Completed | A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atheroscler NCT05355402 | Ionis Pharmaceuticals, Inc. | Phase 2 |
| Unknown | Impact of Foods on Bile Acids, Metabolites, and Inflammation NCT05245357 | Montana State University | N/A |
| Completed | Omega-3 Fatty Acid Dietary Intervention (O3DI) NCT05025943 | Nemours Children's Clinic | N/A |
| Terminated | Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Rec NCT04863014 | Regeneron Pharmaceuticals | Phase 2 |
| Completed | Effects of Replacing Energy From Solid Fats and Added Sugars (SoFAS) With Avocado NCT04990817 | Midwest Center for Metabolic and Cardiovascular Research | N/A |
| Completed | Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment NCT03527069 | EMS | Phase 3 |
| Completed | A Phase 1, First Time in Humans Study of NST-1024 NCT04630366 | NorthSea Therapeutics B.V. | Phase 1 |
| Completed | Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrome (TRISTAN) NCT04650152 | Abbott | — |
| Terminated | Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes NCT04365400 | Afimmune | Phase 2 |
| Completed | Nutritional Transitions to More Plant Proteins and Less Animal Proteins: Understanding the Induced Metabolic R NCT04236518 | University Hospital, Clermont-Ferrand | N/A |
| Completed | Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertrigly NCT04177680 | Matinas BioPharma Nanotechnologies, Inc. | Phase 2 |
| Terminated | A First in Human Study of STT-5058, an Antibody That Binds ApoC3 NCT04419688 | Staten Biotechnology BV | Phase 1 |
| Completed | Impacts of Lentils on Metabolism and Inflammation NCT04283448 | Montana State University | N/A |
| Completed | Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia NCT04239950 | Mochida Pharmaceutical Company, Ltd. | Phase 3 |
| Completed | Long-term Safety and Efficacy Study of MND-2119 in Patients With Hypertriglyceridemia NCT04221217 | Mochida Pharmaceutical Company, Ltd. | Phase 3 |
| Unknown | Interrupting Prolonged Sitting With Periodic Interval Exercise: Effect on Postprandial Lipemia NCT04241081 | University of Texas at Austin | N/A |
| Completed | Intermittent Fasting in Hypertriglyceridemic Overweight or Obese Subjects NCT04143971 | Shahid Beheshti University | N/A |
| Unknown | Characterization of Fatty Acid Composition of Triglycerides in Patients With Hypertriglyceridemia-induced Acut NCT04097990 | Sheba Medical Center | N/A |
| Completed | Adiponectin, ICAM-1, VCAM-1 Levels and Metabolic Syndrome in Obese Adolescents NCT05685017 | Universitas Airlangga | — |
| Unknown | Dark Chocolate, Cholesterol and Microbiota NCT03850405 | University of Bari | N/A |
| Completed | Impact of Plasma Lipids on β Cell Function and Insulin Sensitivity NCT05181514 | Azienda Ospedaliero, Universitaria Pisana | N/A |
| Completed | Impact of Aronia Berry Consumption on Inflammation, Metabolites, and the Gut Microbiome NCT05255718 | Montana State University | N/A |
| Completed | Impacts of Aronia on Inflammation and the Gut Microbiome NCT04128839 | Montana State University | N/A |
| Completed | Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicron NCT03783377 | Arrowhead Pharmaceuticals | Phase 1 |
| Completed | Postprandial Lipid Metabolism in Patients With Hypertriglyceridemia and Normo-lipidemic Controls: Medium Chain NCT03846908 | Ludwig-Maximilians - University of Munich | N/A |
| Completed | Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients NCT03747224 | Arrowhead Pharmaceuticals | Phase 1 |
| Completed | Efficacy of MND-2119 in Participants With Hypertriglyceridemia NCT03693131 | Mochida Pharmaceutical Company, Ltd. | Phase 3 |
| Completed | Translation of Pritikin Program to the Community NCT03929198 | Washington University School of Medicine | N/A |
| Unknown | Intensive Insulin for Severe/Moderate Hypertriglyceridemia Pancreatitis. NCT03501680 | First Affiliated Hospital of Wenzhou Medical University | Phase 4 |
| Completed | Study of Gemcabene in Adults With FPLD NCT03508687 | Elif Oral | Phase 1 / Phase 2 |
| Completed | A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2) NCT03361501 | Grace Therapeutics Inc. | Phase 3 |
| Completed | Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Participants With Hypertriglyceridemia and Established Cardiovascu NCT03385239 | Akcea Therapeutics | Phase 2 |
| Completed | A Prospective Observational Program Using Digital Technology Tools to Enhance Patient Adherence to Omacor Ther NCT03415152 | Abbott | — |
| Completed | A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1) NCT03398005 | Grace Therapeutics Inc. | Phase 3 |
| Completed | Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fat NCT03371355 | Akcea Therapeutics | Phase 2 |
| Unknown | Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertrigly NCT03342807 | Peking Union Medical College Hospital | Phase 4 |
| Completed | Setmelanotide in a Single Patient With Partial Lipodystrophy NCT03262610 | Rhythm Pharmaceuticals, Inc. | Phase 2 |
| Completed | The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN) NCT03120299 | Shanghai Jiao Tong University School of Medicine | Phase 4 |
| Completed | Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therap NCT02926027 | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Phase 4 |
| Completed | Effects of Two Herbal Dietary Supplements on Lipid Metabolism in Moderate Hypercholesterolemia and Hypertrigly NCT02989753 | Valbiotis | Phase 1 / Phase 2 |
| Completed | An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia. NCT04756180 | Abbott | Phase 3 |
| Completed | Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabete NCT02868177 | Valbiotis | Phase 2 / Phase 3 |
| Completed | Feasibility and Acceptability of a Beverage Intervention for Hispanic Adults NCT02911753 | University of Arizona | N/A |
| Completed | Effects of Diet Interventions on Monocytes in Metabolic Syndrome NCT03591588 | Baylor College of Medicine | N/A |
| Completed | Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects NCT02681055 | MediciNova | Phase 2 |
| Unknown | Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides NCT02625870 | Jiangsu HengRui Medicine Co., Ltd. | Phase 3 |
| Completed | Orlistat for the Treatment of Type I Hyperlipoproteinemia NCT02767531 | University of Texas Southwestern Medical Center | Phase 2 |
| Completed | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS ANGPTL3-LRx in Healthy Volunteers With E NCT02709850 | Ionis Pharmaceuticals, Inc. | Phase 1 |
| Completed | A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweigh NCT02354976 | AstraZeneca | Phase 2 |
| Completed | AZD0585 Phase III Long-term Study in Japan NCT02463071 | AstraZeneca | Phase 3 |
| Completed | The COMPASS Study: A Study of Volanesorsen (Formally ISIS-APOCIIIRx) in Patients With Hypertriglyceridemia NCT02300233 | Ionis Pharmaceuticals, Inc. | Phase 3 |
| Completed | Metabolic Effects of Egg Protein and Unsaturated Fat Intakes in Subjects With Hypertriglyceridemia NCT02924558 | Midwest Center for Metabolic and Cardiovascular Research | N/A |
| Completed | A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules NCT02310022 | Matinas Biopharma, Inc | Phase 1 / Phase 2 |
| Completed | Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia NCT02250105 | Arisaph Pharmaceuticals Inc | Phase 2 |
| Completed | Effect of Candida Rugosa Lipase on Serum Triglyceride Lowering NCT05295134 | BIO-CAT, Inc. | N/A |
| Completed | Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia NCT02098278 | Catabasis Pharmaceuticals | Phase 2 |
| Completed | PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester E NCT02113163 | Thetis Pharmaceuticals LLC | Phase 1 |
| Completed | Apolipoprotein CIII Reduction Via Colchicine NCT02083510 | Scripps Translational Science Institute | EARLY_Phase 1 |
| Unknown | Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary NCT02015988 | Koval' O., MD | Phase 4 |
| Completed | PC-300 Tea Effect on Triglyceride Levels NCT03649269 | Ciprés Grupo Médico CGM SC | N/A |
| Completed | Epanova® for Lowering Very High Triglycerides II (EVOLVE II) NCT02009865 | AstraZeneca | Phase 3 |
| Completed | A Pilot Study to Evaluate the Lipid Effects of TRIA-662 NCT02008084 | Cortria Corporation | Phase 2 |
| Completed | Impact of Beans and Oats Snack Bar on Hypertriglyceridemic Women NCT04966494 | Universidad Autonoma de Queretaro | N/A |
| Completed | Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia NCT01968720 | Catabasis Pharmaceuticals | Phase 2 |
| Completed | Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin ( NCT02859129 | AstraZeneca | Phase 1 |
| Unknown | Bioavailability of EPA and DHA From Two Dietary Supplements NCT01908374 | Arctic Nutrition AS | N/A |
| Completed | Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia NCT01912560 | Catabasis Pharmaceuticals | Phase 2 |
| Terminated | Supplementation With Omega-3: Mechanism of Action NCT02036307 | Johns Hopkins University | Phase 2 |
| Completed | Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia an NCT02526121 | Instituto Aragones de Ciencias de la Salud | N/A |
| Completed | Effects Of Consumption Of A Highly Mineralized Sodium Bicarbonated Water On Blood Lipid Profile NCT01819636 | Neptune | N/A |
| Completed | Study to Assess the Safety and Tolerability of Single Doses of REGN1500 NCT01749878 | Regeneron Pharmaceuticals | Phase 1 |
| Completed | Efficacy and Safety Study of DHA-O in Adults With Hypertriglyceridemia NCT01737099 | dsm-firmenich Switzerland AG | N/A |
| Completed | Supplementation of Dual Probiotic Strains Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels NCT02215694 | Yonsei University | Phase 3 |
| Completed | Effects of Acipimox on Mitochondrial Function in Obesity NCT01488409 | Massachusetts General Hospital | Phase 2 |
| Completed | Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease NCT01556113 | Yale University | N/A |
| Completed | Safety, Tolerability, and Pharmacokinetic Study of ISIS ApoC-III Rx in Hypertriglyceridemia NCT01529424 | Ionis Pharmaceuticals, Inc. | Phase 2 |
| Completed | Intestines and Liver Contribution to Fasting Postprandial Hypertriglyceridemia NCT02898142 | Assistance Publique - Hôpitaux de Paris | N/A |
| Suspended | Effects of DPP-4 Inhibition on Triglycerides NCT01527747 | Oregon Health and Science University | Phase 4 |
| Completed | Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell L NCT01569724 | Rennes University Hospital | Phase 4 |
| Completed | Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate NCT01666041 | Gachon University Gil Medical Center | Phase 4 |
| Terminated | Efficacy of LCQ908 on Cardiovascular Risk NCT01474434 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Assess the Safety and Efficacy of NKPL66 (CaPre™) in the Treatment of Mild-to-high Hypertriglyceridemia NCT01516151 | Grace Therapeutics Inc. | Phase 2 |
| Completed | The Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Norma NCT01486433 | AstraZeneca | Phase 1 |
| Completed | A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipid NCT01539616 | Zydus Lifesciences Limited | Phase 2 |
| Completed | A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic NCT01462877 | Abbott | Phase 4 |
| Completed | Intervention With n-3 Polyunsaturated Fatty Acids (PUFA)-Supplemented Products in Moderate Hypertriglyceridemi NCT01437930 | University of Jena | N/A |
| Completed | TRIal For Efficacy of Capre on hyperTriglyceridemiA NCT01455844 | Grace Therapeutics Inc. | Phase 2 |
| Completed | Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of NCT01431690 | AstraZeneca | Phase 1 |
| Completed | [E]PANOVA Combined With a [S]TATIN in [P]ATIENTS With HYPERT[R]IGLYCER[I]DEMIA to Reduce Non-HDL CHOLES[T]EROL NCT01408303 | AstraZeneca | Phase 3 |
| Completed | Fructose Consumption and Metabolic Dysregulation NCT01445730 | Marja-Riitta Taskinen | N/A |
| Completed | An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients NCT01725646 | Excelsior | Phase 3 |
| Unknown | Fish Oil Supplementation and Vascular Function in Hypertensive Patients With Hypertriglyceridemia NCT01480687 | Hospital Universitario Pedro Ernesto | Phase 4 |
| Withdrawn | Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline NCT00901823 | Essentialis, Inc. | Phase 1 |
| Completed | Vascular and Metabolic Effects of Omega-3 Fatty Acids NCT01660932 | Gachon University Gil Medical Center | Phase 4 |
| Withdrawn | Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides NCT00973271 | Essentialis, Inc. | Phase 3 |
| Completed | Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I) NCT01133210 | Washington University School of Medicine | Phase 1 |
| Completed | Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia NCT01211847 | Essentialis, Inc. | Phase 2 |
| Withdrawn | Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia NCT01180764 | University of Utah | Phase 4 |
| Completed | Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204) NCT01245738 | Merck Sharp & Dohme LLC | — |
| Completed | Effects of Amino Acids on Regional Lipid Metabolism NCT01150188 | University of Arkansas | N/A |
| Completed | The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in He NCT01148004 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Completed | Omega-3 Fatty Acid Supplementation in Children NCT01088776 | The Hospital for Sick Children | Phase 2 |
| Completed | Effects of Prescription Omega-3 Acids on Glucose and Lipoprotein Lipids in Subjects With Hypertriglyceridemia NCT01034540 | Provident Clinical Research | N/A |
| Completed | Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) in Metabolic Syndrome NCT01625442 | Birjand University of Medical Sciences | Phase 4 |
| Completed | Hypertriglyceridemia Associated Acute Pancreatitis in Intensive Care Unit and Therapeutic Plasmapheresis NCT05096455 | Centre Hospitalier Universitaire de Nīmes | — |
| Completed | Predictors of Response to Fenofibrate NCT01023750 | University of Alabama at Birmingham | — |
| Completed | Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and NCT01047683 | Amarin Pharma Inc. | Phase 3 |
| Completed | Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels ( NCT01047501 | Amarin Pharma Inc. | Phase 3 |
| Completed | Differential Metabolic Effects of Fenofibrate and Fatty Acid NCT01003847 | Gachon University Gil Medical Center | Phase 4 |
| Completed | Efficacy of TAK-085 in Participants With Hypertriglyceridemia NCT01350973 | Takeda | Phase 3 |
| Completed | Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia NCT01350999 | Takeda | Phase 3 |
| Completed | Lovaza® and Microvascular Function in Type 2 Diabetes NCT00931879 | Eastern Virginia Medical School | Phase 4 |
| Completed | Effects of Lovaza on Lipoprotein Composition and Function in Mild Hypertriglyceridemia NCT00959842 | Sanford Research | Phase 1 / Phase 2 |
| Completed | Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects NCT01010399 | Felizarta, Franco, M.D. | Phase 4 |
| Unknown | Triglyceride Lowering Study NCT00934219 | Jewish Hospital, Cincinnati, Ohio | Phase 4 |
| Unknown | The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabeti NCT00758927 | Inje University | Phase 4 |
| Completed | Fish Oil Study for High Triglyceride Levels in Children NCT00915902 | Babu Balagopal | Phase 2 / Phase 3 |
| Completed | Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard The NCT00887653 | The Miriam Hospital | Phase 3 |
| Completed | Effect of Fish Oil on Plasma Triglycerides in Adults NCT00804427 | Stanford University | N/A |
| Terminated | Effect of Omega-3 Fatty Acid Supplementation on Hypertriglyceridemia in HIV-infected Children NCT00691288 | The Hospital for Sick Children | Phase 2 |
| Completed | Diazoxide Choline in Hypertriglyceridemia NCT00696475 | Essentialis, Inc. | Phase 2 |
| Completed | Effect of Omega-3 Fatty Acids Supplementation on Hypertriglyceridemia in Pediatric Patients With Obesity. NCT03216057 | Hospital Infantil de Mexico Federico Gomez | N/A |
| Completed | Open-label Pharmacokinetic Study of Diazoxide Choline Coated vs. Uncoated Formulations NCT00688857 | Essentialis, Inc. | Phase 1 |
| Terminated | Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides NCT00672633 | Boston Children's Hospital | Phase 2 |
| Terminated | Intravenous Fat Emulsions and Premature Infants NCT01096446 | OSF Healthcare System | N/A |
| Completed | Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) Patients NCT01258322 | Huashan Hospital | N/A |
| Completed | Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients NCT00560430 | Ludwig-Maximilians - University of Munich | Phase 3 |
| Completed | Niacin, N-3 Fatty Acids and Insulin Resistance NCT00286234 | University of South Dakota | Phase 4 |
| Completed | A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA) NCT00519714 | Montreal Heart Institute | Phase 2 / Phase 3 |
| Completed | Beef in an Optimal Lean Diet (BOLD) Effects on Cardiovascular Disease (CVD) Risk NCT00937898 | Penn State University | N/A |
| Completed | Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides NCT00504309 | Penn State University | N/A |
| Completed | Evaluation of Safety and Effects of SLx-4090 After Dosing for 14 Days in Subjects With High Triglycerides NCT00562575 | Response Pharmaceuticals | Phase 2 |
| Completed | Effects of Omega-3 Fatty Acids on Markers of Inflammation NCT01129050 | Stanford University | N/A |
| Completed | Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyce NCT00435045 | GlaxoSmithKline | Phase 3 |
| Completed | Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients NCT00473655 | AstraZeneca | Phase 4 |
| Withdrawn | Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients NCT00397358 | Vantive Health LLC | Phase 4 |
| Completed | Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients NCT00346697 | Brown, Todd, M.D., Ph.D. | Phase 4 |
| Terminated | Laparoscopic Adjustable Gastric Banding With Truncal Vagotomy NCT00329862 | Central Carolina Surgery, PA | N/A |
| Completed | Novel Therapies for Metabolic Complications of Lipodystrophies NCT00457938 | University of Texas Southwestern Medical Center | N/A |
| Completed | Changes in Blood Lipids After Long-term Consumption of n-3 LC-PUFA-Enriched Dairy Products NCT00639041 | University of Jena | N/A |
| Completed | A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of NCT00891293 | GlaxoSmithKline | Phase 4 |
| Terminated | Fat Tolerance From Lipid Emulsion Infusion Packaged in Glass or Plastic NCT00278928 | Beth Israel Deaconess Medical Center | N/A |
| Completed | Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety NCT00903409 | GlaxoSmithKline | Phase 3 |
| Completed | Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hy NCT00246701 | GlaxoSmithKline | Phase 3 |
| Completed | Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceride NCT00246636 | GlaxoSmithKline | Phase 4 |
| Completed | Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy NCT00109603 | National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
| Completed | Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals. NCT00540111 | UPECLIN HC FM Botucatu Unesp | N/A |
| Completed | A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Tri NCT00134498 | Pfizer | Phase 3 |
| Completed | Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic Patients NCT00745407 | Gachon University Gil Medical Center | Phase 4 |
| Completed | A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED) NCT00093899 | Organon and Co | Phase 3 |
| Completed | Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides NCT00108511 | US Department of Veterans Affairs | Phase 1 |
| Terminated | Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy NCT00080132 | Medical Research Laboratories International | Phase 2 |
| Completed | Pharmacogenetics of Hypertriglyceridemia in Hispanics NCT00086437 | University of California, Los Angeles | — |
| Completed | Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystr NCT00246376 | Baylor College of Medicine | N/A |
| Completed | Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerid NCT00186537 | Stanford University | N/A |
| Completed | Docosahexenoic Acid (DHA) Supplementation and Cardiovascular Disease in Men With High Triglycerides NCT00728338 | USDA, Western Human Nutrition Research Center | N/A |
| Completed | Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED) NCT00092573 | Organon and Co | Phase 3 |
| Completed | Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036) NCT00092560 | Organon and Co | Phase 3 |
| Completed | Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV NCT00246402 | National Heart, Lung, and Blood Institute (NHLBI) | N/A |
| Completed | Effect of Changing Diet on Fasting and Post Fat Load Lipoproteins NCT00593424 | University of Arkansas | N/A |
| Completed | Genetic Determinants:Low HDL, High Triglycerides, Obesity NCT00049881 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Withdrawn | Garlic in Hyperlipidemia Caused by HAART NCT00029250 | National Center for Complementary and Integrative Health (NCCIH) | Phase 2 |
| Completed | Pharmacological Regulation of Fat Transport in Metabolic Syndrome NCT00632840 | The University of Western Australia | Phase 4 |
| Terminated | A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia NCT00231621 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 |
| Completed | Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides NCT02585869 | NeuroBo Pharmaceuticals Inc. | Phase 2 |
| Completed | Regulation of Sterol Homeostasis NCT00018720 | US Department of Veterans Affairs | — |
| Completed | Re-evaluating Triglycerides in Coronary Heart Disease NCT00005442 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients NCT00046267 | National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
| Completed | The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral T NCT00076518 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |